Starlog Enterprises approves up to Rs 5 crore fund infusion into subsidiary Starport Logistics

What Starlog Enterprises announced

On 23 June 2026, the Board of Directors of Starlog Enterprises Limited (BSE: 520155) met and resolved to provide additional capital to its wholly‑owned subsidiary, Starport Logistics Limited. The board approved a fund infusion not exceeding Rs 5 crore. The infusion may be executed in one or more tranches and can take the form of subscription to securities (equity) or a loan, which may be convertible or non‑convertible, as the board deems appropriate.

"The Board approved further infusion of funds not exceeding INR 5 Crore into Starport Logistics Limited, a wholly owned subsidiary of the Company, in one or more tranches, either by way of subscription in its securities or by way of loan (convertible or otherwise)."

The announcement was filed with the Bombay Stock Exchange under Regulation 30 of the Listing Regulations.

Details of the approved fund infusion

• Maximum amount: Rs 5 crore (approximately USD 6 million). The exact amount to be transferred will be decided by the board in subsequent meetings.
• Tranche structure: The infusion may be split across multiple disbursements, allowing flexibility to align with Starport Logistics' cash‑flow needs.
• Mode of funding: Two alternatives are permitted:
  1. Equity subscription – the parent may subscribe to newly issued shares of Starport Logistics, potentially diluting existing shareholders of the subsidiary (though the parent already holds 100 %).
  2. Loan – a debt instrument, which may be convertible into equity at a later date, or remain a plain loan.
• Purpose: The filing does not specify a particular use of the funds; it merely states the infusion is to support the subsidiary’s operations.

Conditions and regulatory compliance

The infusion is subject to compliance with applicable laws, statutory approvals, consents and permissions. This includes:

• Approval from the Registrar of Companies and any sector‑specific regulator, if required.
• Board and shareholder approvals for any issuance of securities, as per the Companies Act, 2013.
• Compliance with the Listing Regulations for related‑party transactions, given the parent‑subsidiary relationship.

No further details on timelines or the exact instrument terms were disclosed in the filing.

Key facts at a glance

Why this matters for investors

The approval signals that Starlog Enterprises is willing to allocate additional capital to its logistics arm, potentially strengthening Starport Logistics' balance sheet and operational capacity. Because the parent already owns 100 % of the subsidiary, any equity subscription will not dilute external shareholders of Starlog Enterprises, but it may affect the consolidated financial statements through increased assets or liabilities, depending on the chosen instrument. The requirement for statutory approvals means the actual transfer may occur after the filing date, and the final terms (interest rate, conversion ratio, etc.) remain undisclosed.

Conclusion

Starlog Enterprises' board has cleared a flexible, up‑to‑Rs 5 crore capital infusion for Starport Logistics, with the method of funding to be decided later. The transaction awaits the necessary regulatory and statutory clearances before execution. Investors should monitor subsequent disclosures for details on tranche timing, instrument specifics, and any impact on the consolidated financials.